undefined undefined
NaN.000
NaN.00%
The analysts covering IDEAYA Biosciences, Inc. (NASDAQ:IDYA) delivered a dose o...
05-12 21:30
Unity Software(U.US) reported fourth-quarter financial results after the market...
05-08 22:12
Wedbush analyst Robert Driscoll reiterated a Buy rating on IDEAYA Biosciences (...
05-08 20:27
Analyst Tim Chiang from Capital One Financial maintained a Buy rating on IDEAYA...
05-08 09:35
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-08 09:11
IDEAYA Biosciences (NASDAQ:IDYA) reported quarterly losses of $(0.53) per share which met the analyst consensus estimate.
05-07 18:13
SOUTH SAN FRANCISCO, Calif., April 5, 2024 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of target...
04-05 18:00
Immunocore Holdings (NASDAQ:IMCR) disclosed in an SEC filing on Wednesday after the bell a prospectus to offer and sell ordinary shares, American Depositary Shares representing ordinary shares, debt s...
03-21 22:56
In the last three months, 6 analysts have published ratings on IDEAYA Bioscienc...
03-09 04:00